Contact us
Let us know about your remote blood biomarker monitoring needs.
50 Milk Street
16th floor
Boston, MA 02109
contact@generalprognostics.com
A bloodless future for healthcare?
Blood tests are the gold standard for predicting disease progression. Unfortunately, blood tests may also be time consuming, expensive, and painful. What if your smartwatch could tell you when vital blood biomarkers change?
Our Purpose
GPx is enhancing remote patient management by building a new class of biomarkers called Bloodless Blood Tests. Through our AI-powered Canary Prediction Engine, digital biomarkers collected from patient wearables and peripherals transform into an unparalleled window into patient blood biomarker status. With this data, physicians benefit from presymptomatic detection of critical patient condition changes, enabling timely treatment that avoids hospital readmissions.
Our News
Find out the latest on GPx
Pitch competition underway at #HRX2022!
Moderated by @GSMedicine - 5 companies:
@RelayResponse l
@GPx_Boston
@ReadMyRhythm
@anumanainc
@VP_Exam
All vying for the top spot!
Learn about them in the thread 🧵 ⤵️
cc: @JagSinghMD @SanaAlkhatib9 https://twitter.com/Nishaki1/status/1568586186553442310
#HRX2022 excited to be a judge for the pitch competition this am:
ReadMyRhythm: integrating&triaging wearable ecg reads
General Prognostics (GPX): bloodless biomarkers
Anumana: new AI algrthms w 3 s/p Fda clearance
VPExam:compr virtual exams
RelayResponse: CPR on an app